WO WO2018187698
· 2018
[cited by applicant]
WO WO2019006427
· 2019
[cited by applicant]
Liu et al., (2021) Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Sci. Transl. Med., 13: https://doi.org/10.1016/j.ijbiomac.2025.141573 (Year: 2021).
[cited by examiner]
Liu et al., (2018) Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition. Nat Commun., 9: 249 (Year: 2018).
[cited by examiner]
Liu et al., (2021) Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Science Translational Medicine, 13(587): eaaz6314 (Year: 2021).
[cited by examiner]
Tessier et al., (2002) Implication of three isoforms of PLA2 in human T-cell proliferation. FEBS Letters, 520(1-3): pp. 111-116 (Year: 2002).
[cited by examiner]
Berod, et al. “De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells”,
[cited by applicant]
Buck, et al. “Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming”.
[cited by applicant]
Chuang et al., “Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway”,
[cited by applicant]
Feuerherm et al., “Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis”,
[cited by applicant]
Ford, “Saturated fatty acid metabolism is key link between cell division, cancer, and senescence in cellular and whole organism aging”,
[cited by applicant]
Fujimoto, “Not just fat: the structure and function of the lipid droplet”,
[cited by applicant]
Gubern, et al. “Group IVA phospholipase A2 is necessary for the biogenesis of lipid droplets”,
[cited by applicant]
International Search Report and Written Opinion for PCT/US2020/033530 dated Aug. 28, 2020 (16 pages).
[cited by applicant]
Kalyvas et al., “Cytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease”, 4, pp. 323-333, 2004.
[cited by applicant]
Linkous et al., “Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis”,
[cited by applicant]
Liu et al., “Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition”
[cited by applicant]
Malda-Edelstein et al., “Regulatory role of cytosolic phospholipase A2 alpha in the induction of CD40 in microglia”,
[cited by applicant]
Michalek, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.
[cited by applicant]
NCBI, “PLA2G4A phospholipase A2 group IVA [
[cited by applicant]
Patel et al., Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer,
[cited by applicant]
Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism.
[cited by applicant]
Peng, et al. “Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function”,
[cited by applicant]
Peng, et al. “Tumor-infiltrating gamma-delta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway”,
[cited by applicant]
Penno, “Phospholipids and lipid droplets”,
[cited by applicant]
Sharma, “Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential”,
[cited by applicant]
Shi, et al. “HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells”,
[cited by applicant]
Thotala et al., “Cytosolic PhospholipaseA2 Inhibition with PLA-695 Radiosensitizes Tumors in Lung Cancer Animal Models”
[cited by applicant]
Topalian, “Immune checkpoint blockade: a common denominator approach to cancer therapy”,
[cited by applicant]
Yang et al. “Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism.”
[cited by applicant]
Yang, “Protective Effect of Cytosolic Phospholipase A2 Inhibition against Inflammation and Degeneration by Promoting Regulatory T Cells in Rats with Experimental Autoimmune Encephalomyelitis”,
[cited by applicant]
Ye & Peng, “Controlling T cell senescence in the tumor microenvironment for tumor immunotherapy”,
[cited by applicant]
Ye, J. et al. Human regulatory T cells induce T-lymphocyte senescence. Blood 120, 2021-2031, doi:blood-2012-03-416040 [pii] 10.1182/blood-2012-03-416040 (2012).
[cited by applicant]
Ye, J. et al. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.
[cited by applicant]
Ye, J. et al. Tumor-derived gammadelta regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
[cited by applicant]
Zou, “PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations”,
[cited by applicant]